Hepatology Self-Assessment Program

5 (10 votes)

The goal of Hepatology Self-Assessment Program (HSAP) is a quick way for physicians and health professionals who diagnose and treat patients with liver disease to guide their self-assessment of medical knowledge utilizing short quizzes based on topics from the ABIM Certification/ Maintenance of Certification Exam Blueprint in Transplant Hepatology. Practice with board-style questions can help to identify knowledge gaps and link learners to resources for additional self-study when these gaps are identified. 

Release Date: November 8, 2019
Expiration Date: November 7, 2022

Upon completion of this activity, learners will be able to: 

1) Identify knowledge gaps and target study to fill those gaps in preparation for the ABIM Certification/Maintenance of Certification Exam in Transplant Hepatology

2) Identify resources available through the AASLD to facilitate self-assessment in preparation for MOC examinations in Transplant Hepatology

Hepatologists   
Gastroenterologists       
Nurse Practitioners        
Physician Assistants               
Fellows/Trainees
Primary Care Physicians
Family Practice Physicians
Internal Medicine Physicians
Medical Students

Satisfactory completion 

Participants must pass a post-test with a score of 70% or higher and complete an evaluation to receive a certificate of completion. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your board requirement. All sessions must be viewed and all post-tests must be completed successfully to earn credits or points for this activity. Please note, no partial credits or points will be given.  

Credits Offered Continuing Medical Education (CME): 2.5 AMA PRA Category 1 Credits™; Maintenance of Certification (ABIM MOC): 2.5 MOC Points

Accreditation and Designation Statements

Continuing Medical Education (CME):

The American Association for the Study of Liver Diseases (AASLD) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. AASLD designates this live activity for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM Maintenance of Certification (ABIM MOC): 

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.

ABP Maintenance of Certification (ABP MOC):

Successful completion of this CME activity, which includes participation in the activity and individual assessment of and feedback to the learner, enables the learner to earn up to 2 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.

Claiming CME Credits Physicians and other health care professionals seeking 2.5 AMA PRA Category 1 Credits™ for this enduring continuing medical education activity must complete an evaluation by November 7, 2022. 

Claiming ABIM MOC Points Physicians seeking ABIM and or ABP MOC points must complete the CME and MOC evaluation by November 7, 2022. Requests for MOC after this date will not be honored. The MOC evaluation is included in the CME evaluation.

MOC Points will be reported to the ABIM and ABP by the end of each month through November 2022 for individuals who successfully complete the MOC evaluation.

DISCLOSURE OF CONFLICTS OF INTEREST

AASLD requires all individuals who are in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. Disclosures are collected prior to the start of the educational activity. Any potential conflicts of interest that exist are resolved prior to implementation of the activity. All disclosures are made available and communicated to the leaner prior the activity beginning.

The organizers and faculty have reported the following disclosures:

Question Writers, Editors and Reviewers 

Oren K. Fix, MD, MSc, FAASLD
Nothing to disclose

Heather M. Patton, MD, FAASLD
Nothing to disclose

Helen S. Te, MD, FAASLD
Research Grants: Conatus Pharmaceuticals, Abbvie, Gilead Sciences
Advisory Board: Gilead Sciences,Intercept Pharmaceuticals

Mark W. Russo, MD, MPH, FAASLD
Commercial Speaker's Bureau: Gilead, Abbvie,Intercept, Salix

Katie Duggan, BA
Staff Liaison
Nothing to disclose

Maintenance of Certification Committee

Mark W. Russo, MD, MPH, FAASLD
Chair
Commercial Speaker's Bureau: Gilead, Abbvie,Intercept, Salix

Raymond T. Chung, MD, FAASLD
Board Liaison
Research Grants: Abbvie, Gilead Sciences, Boehringer Ingelheim

Curtis K. Argo, MD, MS, FAASLD
Member
Nothing to disclose

Steven K. Herrine, MD, FAASLD
Member
Research Grants: Gilead, BMS, Galectin, Interecept 
Leadership in related society: Board, Committee, Journal: ABIM - Chair, Transplant Hepatology Test Committee

Vandana Khungar, MD, MSc
Member
Nothing to disclose

Ayman A. Koteish, MD, FAASLD
Member
Nothing to disclose

Smruti R. Mohanty, MD, MS
Member
Advisory Board: Gilead science, Abbvie, Merck, Bristol Meyers Squib and Intercept
Leadership in related society: Board, Committee, Journal: Publications Committee, American College of Gastroenterology (2009- Present) Education Committee Member, the Alliance for Academic Internal Medicine (AAIM) (July 2016-19) Editorial Board, World Journal of Gastroenterology (2007-Present) Editorial Board, Digestive Disease & Science (2009-Present) Editorial Board, World Journal of Hepatology

Heather M. Patton, MD, FAASLD
Member
Nothing to disclose

K. Gautham Reddy, MD, FAASLD
Member
Scientific Consultant/Advisor to Industry or Commercial Enterprise, including Development of Educational Presentations: Intercept, Gilead
Research Grants: Merck Intercept Genfit
Commercial Speaker's Bureau: Intercept
Leadership in related society: Board, Committee, Journal: Member, Training Committee: American College of;

Grace L. Su, MD, FAASLD
Member
Company: Management Position

Ryan M. Taylor, MD
Member
Commercial Speaker's Bureau: Merck, Inc., Abbvie, Inc., Intercept Pharmaceuticals, Inc., Gilead Sciences, Inc., Bristol-Myers Squibb

Helen S. Te, MD, FAASLD
Member
Research Grants: Conatus Pharmaceuticals, Abbvie, Gilead Sciences
Advisory Board: Gilead Sciences,Intercept Pharmaceuticals

Debra Guss, RN, NP-C, ACRN
Associate
Nothing to disclose

Katie Duggan, BA
Staff Liaison
Nothing to disclose

Key:

Complete
Failed
Available
Locked
Quiz
10 Questions  |  Unlimited attempts  |  7/10 points to pass
10 Questions  |  Unlimited attempts  |  7/10 points to pass
CME Credits
Up to 2.50 medical credits available  |  Certificate available
Up to 2.50 medical credits available  |  Certificate available
Acknowledgement of MOC Submission
Agree to terms to continue.
Agree to terms to continue.
ABIM MOC Points
Up to 2.50 medical credits available  |  Certificate available
Up to 2.50 medical credits available  |  Certificate available
ABP MOC Points
Up to 2.00 medical credits available  |  Certificate available
Up to 2.00 medical credits available  |  Certificate available